SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-18-014959
Filing Date
2018-03-15
Accepted
2018-03-15 17:01:01
Documents
1
Period of Report
2018-03-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 tv488494_form4.html 4  
1 FORM 4 tv488494_form4.xml 4 4048
  Complete submission text file 0001144204-18-014959.txt   5555
Mailing Address 205 EAST 42ND STREET, 17TH FLOOR NEW YORK NY 10017
Business Address 205 EAST 42ND STREET, 17TH FLOOR NEW YORK NY 10017 (973) 242-0005
Neurotrope, Inc. (Issuer) CIK: 0001513856 (see all company filings)

IRS No.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address IROQUOIS CAPITAL MANAGEMENT LLC 205 EAST 42ND ST - 20TH FL. NEW YORK NY 10017
Business Address
Silverman Joshua (Reporting) CIK: 0001524858 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38045 | Film No.: 18693198